Press Releases Theraclion

Equities

ALTHE

FR0010120402

Market Closed - Euronext Paris Other stock markets 08:44:50 07/05/2024 pm IST			5-day change	1st Jan Change
0.41 ^EUR	+2.76%		+11.72%	+5.67%

27/03	Theraclion SA Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Theraclion Achieves an Important Milestone on the Road to the U.S. Market: First Patients Treated with Sonovein as Part of the Fda- Approved Pivotal Study	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Theraclion Announces 2023 Financial Results and Continues Its Roadmap	27/03	BU
Theraclion : announces 2023 financial results and continues its roadmap	27/03	PU
Theraclion : Présentation AGM – 29 juin 2023	21/12	PU
Theraclion : Presentation AGM 29 juin 2023	24/23/24	PU
THERACLION : ANNOUNCES 2022 FINANCIAL RESULTS AND INFORMS ON THE COMPANY’S SHORT-TERM FINANCING	28/23/28	PU
THERACLION : SUCESSFULLY REPRESENTATED AT THE 8TH INTERNATIONAL SYMPOSIUM ON FOCUSED ULTRASOUND	14/22/14	PU
Theraclion : Last patient of first SONOVEIN® US study has been treated	17/22/17	PU
Theraclion : AGM 2022 Présentation	30/22/30	PU
Theraclion : Inside Information / Other news releases	24/22/24	PU
Theraclion : is deploying its scalable robotic platform SONOVEIN® in Europe	15/21/15	PU
Theraclion : results show strong recovery, allowing ambitious plans	23/21/23	PU
Theraclion : FDA approves the 1st trial with Theraclion’s vein therapy in the US	20/21/20	PU
Theraclion : Bernard Sabrier and Unigestion pass the 20% threshold, proof of confidence in the company’s development	10/21/10	PU
Theraclion : UVA Cancer Center to expand use of Theraclion’s HIFU system in cancer treatment research.	02/21/02	PU
Theraclion : In 2020, Theraclion has succeeded a crucial step for its technology.	23/21/23	PU
In 2020, Theraclion Has Succeeded a Crucial Step for Its Technology: Results Allow Further Expansion for the Next Two Years	22/21/22	BU
Theraclion : Strategy Is in Place for 2021 Despite the Impact of Covid-19 on Sales Revenues For 2020	19/21/19	BU
Theraclion : strategy is in place for 2021 despite the impact of Covid-19 on sales revenues for 2020	19/21/19	PU
Theraclion : Renewed Investor Confidence in Theraclion	17/20/17	BU
Theraclion : Positive and Differentiated Results for Theraclion’s Non-invasive Varicose Vein Treatment Technology Revealed at The 34th AVLS	21/20/21	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Theraclion

Equities

ALTHE

FR0010120402

Press Releases

Filters